11/18
08:00 am
adtx
Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, And Evofem’s Plan to Regain a National Listing
High
Report
Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, And Evofem’s Plan to Regain a National Listing
10/29
04:30 pm
adtx
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025
High
Report
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025
10/27
08:30 am
adtx
Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market
High
Report
Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market
10/20
04:19 pm
adtx
Evofem Announces Voting Results from Special Meeting of Stockholders
High
Report
Evofem Announces Voting Results from Special Meeting of Stockholders
10/3
02:47 pm
adtx
Aditxt (NASDAQ:ADTX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Aditxt (NASDAQ:ADTX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.